INOVIO remains confident in the therapy’s benefits and intends to meet with the FDA to discuss maintaining eligibility under this pathway
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
Under the terms of the deal, AstraZeneca gains exclusive rights to JAB-23E73 outside of mainland China
If approved, imlifidase has the potential to transform the kidney transplant landscape by enabling highly sensitized patients to also have access to a potentially life-changing kidney transplant
Production at Biocon Biologics’ own facilities is scheduled to begin once technology transfers and regulatory approvals are finalized
NUFYMCO BLA has been approved by the USFDA
The company along with its subsidiaries has overall bed capacity of 8800+ beds as on 30th September, 2025
Under the agreement, AVT06 is licensed to enter the US market in the fourth quarter of 2026
The approval comes with 180 days of Competitive Generic Therapy (CGT) exclusivity,
Subscribe To Our Newsletter & Stay Updated
